VC Catalog · venture ecosystem research library
VC Catalog home Beta

Company

Ampyra

Rocket Ship RatingBased on the data VC Catalog holds.

Rocket Ship Rating: 77 out of 100

AMPYRA® (dalfampridine) Extended Release Tablets, 10 mg

  • Biotech & therapeutics
Status
Operatingas of 2026-09-17
Open relationship map
Claim, correct or request removal

Record updated 28 September 2026

About

AMPYRA (dalfampridine) Extended Release Tablets, 10 mg, is indicated to help improve walking in adults with multiple sclerosis (MS). This was demonstrated by an increase in walking speed.

Products

Other
AMPYRA (dalfampridine) Extended Release Tablets, 10 mg
Loading relationship preview

Cookies on VC Catalog

We use necessary cookies to run the site (sign-in, security, remembering this choice). With your permission we also use Google Analytics to understand how the site is used. Analytics cookies are set only if you accept all cookies. Privacy policy